Opioid overdoses can happen to anyone, anywhere, anytime. We have teamed up with Emmitt Smith to educate the public on proper administration of NARCAN® Nasal Spray in the event of an opioid overdose emergency by remembering three simple words: Lay, Spray, Stay. Learn more and use as directed: https://lnkd.in/gNYeHPcT #ReadyToRescue #EmergentPartner
Emergent BioSolutions
Biotechnology Research
Gaithersburg, Maryland 41,419 followers
Protecting against emerging global health threats.
About us
At Emergent, we develop, manufacture, and deliver protections against public health threats. For more than two decades, we’ve been at work defending people from things we hope will never happen — so that we’re prepared, just in case they ever do. Please note: It has come to our attention that there may be people posing as Emergent recruiters and hiring managers online, offering fraudulent opportunities to job seekers. Emergent will never ask for any financial commitment from a candidate as a pre-employment requirement. Learn more about recruitment fraud and how to protect yourself here: https://bit.ly/recruitment-fraud
- Website
-
https://www.emergentbiosolutions.com/
External link for Emergent BioSolutions
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Gaithersburg, Maryland
- Type
- Public Company
- Founded
- 1998
- Specialties
- Manufacturing, Partnering, M&A, Devices Development, Vaccine Development, Therapeutics Development, and Contract Development and Manufacturing
Locations
Employees at Emergent BioSolutions
Updates
-
Emergent BioSolutions Announces Shelf-Life Extension for NARCAN® Nasal Spray in Canada. Learn more: https://lnkd.in/e7sugU6Y
-
According to a National Safety Council survey, 75% of U.S. employers have been directly affected by opioid use but only 17% feel extremely well prepared to deal with the issue. Incorporating naloxone into your employee safety plan is one step you can take to help combat opioid overdoses in the workplace. Read more: https://lnkd.in/etBaUwF
Poll: 75% of Employers Say Their Workplace Impacted by Opioid Use - National Safety Council
nsc.org
-
Providing more access to naloxone kits in public places is safe and can reduce opioid overdose deaths. The American Medical Association recently adopted new policy to support the expansion of naloxone availability by locating intranasal naloxone along with automated external defibrillators (AEDs) in public locations. Read more: https://lnkd.in/gFKfAb5e
Put naloxone next to defibrillators in public places
ama-assn.org
-
Being ready to rescue means being prepared to respond to an opioid overdose emergency anytime and anywhere, including at work. Learn more about how your workplace can become ready to rescue: https://lnkd.in/gQM-PuH3
Workplace | NARCAN® (naloxone HCl) Nasal Spray
narcan.com
-
Today Emergent highlighted several recent advancements in improving our financial health, marked by robust cash generation and meaningful debt repayment. Read more: https://lnkd.in/gHthuvZP
Emergent BioSolutions Continues to Drive Improved Financial Position as Part of Multi-Year Transformation Plan | Emergent BioSolutions Inc.
investors.emergentbiosolutions.com
-
Ahead of the UK general election, Ask Eirik Storsve, Head of European Government Affairs, shares how the next government can prepare for biological and chemical threats. Learn more: https://lnkd.in/ekUz8FQ7
How the next Government can be better prepared for biological and chemical threats - National Preparedness Commission
https://nationalpreparednesscommission.uk
-
Update: Today Emergent announced it has received more than $250 million in contract modifications from the Administration for Strategic Preparedness and Response (ASPR) at the United States Department of Health and Human Services (HHS), to deliver millions of doses of four medical countermeasures.
Update: Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products | Emergent BioSolutions Inc.
investors.emergentbiosolutions.com
-
Today Emergent announced the sale of its Baltimore-Camden manufacturing site. Learn more.
Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million
investors.emergentbiosolutions.com
-
On June 19, Emergent will close for the day in commemoration and recognition of Juneteenth, a day to remember, learn about, and celebrate African American freedom. #Juneteenth
-
Affiliated pages
Similar pages
Browse jobs
Stock
EBS
NYSE
20 minutes delay
$13.80
1.31 (10.488%)
- Open
- 12.26
- Low
- 11.93
- High
- 13.966
Data from Refinitiv
See more info on